Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Reversing the Tide: Priorities for HIV/AIDS Prevention in Central Asia

Faced with four overlapping epidemics -- drug use, sexually transmitted infections, HIV/AIDS, and tuberculosis -- Central Asia may face a serious crisis in 20 years' time unless concerted action is taken now. This study, geared to policymakers, provides an epidemiological update and looks at actions taken already by governments, NGOs, and donors in four Central Asian countries. It finds that injecting drug users, sex workers, prisoners and youth at risk are barely attended to, while truck drivers and migrants are overlooked all together.

Author:

Godinho J.; Renton A.; Vinogradov V.; et al

Audiences:

Policy Makers

Topic:

Outbreaks, HIV Co-infection, Partnership Building

Related Materials

Priority Research Questions for TB/HIV in HIV-Prevalent and Resource-Limited Settings

This document is intended to raise awareness about TB/HIV research priorities (i.e. areas that require urgent funding and scientific interest), help coordinate advocacy efforts, and encourage research funding. The aim is to increase the implementation of high-quality, integrated TB/HIV interventions in resource-limited settings. The document outlines a revised research priority agenda based on the latest evidence in six key areas of TB and HIV co-infection.

Report

MMWR: Updated Guidelines for the Use of Rifabutin or Rifampin for the Treatment and Prevention of Tuberculosis Among HIV-Infected Patients Taking Protease Inhibitors or Nonnucleoside Reverse Transcriptase Inhibitors

This guideline presents updated data about drug interactions between protease inhibitors and non-nucleoside reverse transcriptase inhibitors for treatment of HIV infection together with rifamycins for treatment of TB.

Guideline

TB/HIV Research Priorities in Resource-Limited Settings: Report of an Expert Consultation

This report is an outline of the Expert Consultation on TB/HIV Research Priorities in Resource-limited Setting on 14-16 February 2005 in Geneva, Switzerland. Three discussion groups identified research priorities for five major areas: (1) preventive therapy for TB were identified with a distinction between the population and the individual levels; (2) co-trimoxazole prophylaxis including the role of co-trimoxazole in the context of antiretroviral therapy, delivery strategies, and determining the efficacy of and optimal time for initiating co-trimoxazole prophylaxis among people living with HIV/AIDS and TB; (3) antiretroviral therapy for people living with HIV/AIDS who have TB or who develop TB is validating the optimal time for initiating antiretroviral therapy; (4) intensified case-finding focus on ways to put this TB/HIV collaborative activity into operation to improve TB control; and (5) the development of new tools and diagnostic algorithms to improve the diagnosis of smear-negative TB in adults and children.

Report

Global resources for the prevention,
management, and elimination of TB.